Dimensional Fund Advisors’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180K Hold
11,280
﹤0.01% 3085
2026
Q1
$101K Buy
+11,280
New +$77.1K ﹤0.01% 3119
2024
Q4
Sell
-2,650
Closed -$24.8K 3358
2024
Q3
$24.8K Hold
2,650
﹤0.01% 3326
2024
Q2
$28.4K Hold
2,650
﹤0.01% 3340
2024
Q1
$39.2K Sell
2,650
-1,055
-28% -$14.7K ﹤0.01% 3343
2023
Q4
$70.8K Sell
3,705
-395
-10% -$9.65K ﹤0.01% 3315
2023
Q3
$111K Sell
4,100
-176
-4% -$7.62K ﹤0.01% 3301
2023
Q2
$194K Buy
4,276
+463
+12% +$22.7K ﹤0.01% 3240
2023
Q1
$174K Buy
+3,813
New +$197K ﹤0.01% 3230
2022
Q3
$335K Buy
+2,896
New +$258K ﹤0.01% 3136

Other funds holding RLYB

Dimensional Fund Advisors's RLYB Position: Q2 2026 in Review

Dimensional Fund Advisors held its Rallybio (RLYB) position steady in Q2 2026 at 11,280 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

Dimensional Fund Advisors first reported a position in RLYB in Q3 2022 and has held it in 10 quarters since. The position peaked at $335K in Q3 2022. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Dimensional Fund Advisors held 11,280 shares of Rallybio worth $180K as of Q2 2026.
  • Dimensional Fund Advisors left its Rallybio share count unchanged in Q2 2026.
  • Rallybio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3085 holding.
  • Dimensional Fund Advisors first reported a position in Rallybio in Q3 2022 and has held it in 10 quarters since.
  • Dimensional Fund Advisors's Rallybio position peaked at $335K in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.